Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: tazarotene

« Back to Dashboard
Tazarotene is the generic ingredient in three branded drugs marketed by Stiefel Labs Inc and Allergan, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has twenty-one patent family members in thirteen countries.

There are seven drug master file entries for tazarotene. Three suppliers are listed for this compound.

Summary for Generic Name: tazarotene

Tradenames:3
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list7
Suppliers: see list3
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: tazarotene

Ingredient-typeRetinoids
Drug ClassRetinoid

Clinical Trials for: tazarotene

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
TAZORAC
tazarotene
GEL;TOPICAL020600-002Jun 13, 1997RXYes<disabled><disabled>
Allergan
TAZORAC
tazarotene
CREAM;TOPICAL021184-002Sep 29, 2000RXYes<disabled><disabled>
Allergan
TAZORAC
tazarotene
GEL;TOPICAL020600-001Jun 13, 1997RXYes<disabled><disabled>
Stiefel Labs Inc
FABIOR
tazarotene
AEROSOL, FOAM;TOPICAL202428-001May 11, 2012RXYes<disabled><disabled>
Stiefel Labs Inc
FABIOR
tazarotene
AEROSOL, FOAM;TOPICAL202428-001May 11, 2012RXYes8,808,716<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: tazarotene

Country Document Number Publication Date
Japan2013516283May 13, 2013
China102665807Sep 12, 2012
Mexico2011008912Sep 09, 2011
Canada2784041Jul 14, 2011
Philippines12014501461Oct 20, 2014
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc